Latest ebit for MDMG.ME: $9.4B, below the sector sector average of $2.3T.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2025
Trailing 12 months ending Jun 30, 2025
The latest EBIT for MDMG.ME is $9.4B as of June 2025. That compares with $5.9B in the prior-year period — up 58.6% year over year. That is below the sector sector average of $2.3T. Investors often review this figure alongside MD Medical Group Investments Plc's historical trend and sector peers before judging valuation or financial health.
Over the past year, MDMG.ME's EBIT moved from $5.9B to $9.4B — a 58.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MD Medical Group Investments Plc's operating scale or balance-sheet position.
Against its sector companies, MDMG.ME currently prints $9.4B for EBIT, while the sector average sits near $2.3T. That is roughly 99.6% below the sector mean. Large gaps often invite a closer look at MD Medical Group Investments Plc's growth, margins, and balance sheet.
A EBIT figure of $9.4B for MDMG.ME is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.3T. Explore the charts below for those layers of context.
After noting MDMG.ME's EBIT ($9.4B), review year-over-year change from $5.9B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.